Citadel Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.3M Buy
937,300
+17,600
+2% +$1.32M 0.01% 1118
2025
Q4
$72.6M Sell
919,700
-123,100
-12% -$9.74M 0.01% 1099
2025
Q3
$85.9M Buy
1,042,800
+163,800
+19% +$12.9M 0.01% 953
2025
Q2
$70.7M Buy
879,000
+326,800
+59% +$25.2M 0.01% 988
2025
Q1
$44.3M Sell
552,200
-507,400
-48% -$42.2M 0.01% 1241
2024
Q4
$86.8M Sell
1,059,600
-101,800
-9% -$8.47M 0.02% 828
2024
Q3
$95.8M Sell
1,161,400
-25,400
-2% -$1.9M 0.02% 724
2024
Q2
$83.3M Sell
1,186,800
-131,700
-10% -$9.4M 0.02% 788
2024
Q1
$97.7M Sell
1,318,500
-1,177,800
-47% -$82.1M 0.02% 711
2023
Q4
$165M Sell
2,496,300
-930,600
-27% -$58.2M 0.03% 430
2023
Q3
$216M Buy
3,426,900
+982,500
+40% +$61.2M 0.05% 295
2023
Q2
$138M Sell
2,444,400
-443,700
-15% -$24.6M 0.03% 454
2023
Q1
$167M Buy
2,888,100
+743,100
+35% +$50.2M 0.04% 394
2022
Q4
$155M Buy
2,145,000
+23,100
+1% +$1.65M 0.04% 437
2022
Q3
$129M Buy
2,121,900
+371,300
+21% +$23.7M 0.03% 480
2022
Q2
$110M Buy
1,750,600
+388,900
+29% +$25.7M 0.03% 529
2022
Q1
$95.7M Buy
1,361,700
+171,900
+14% +$11.6M 0.02% 680
2021
Q4
$74.4M Buy
1,189,800
+57,100
+5% +$3.58M 0.02% 875
2021
Q3
$69.9M Sell
1,132,700
-11,400
-1% -$686K 0.01% 883
2021
Q2
$68.5M Buy
1,144,100
+366,200
+47% +$23.2M 0.02% 900
2021
Q1
$47.3M Buy
777,900
+95,900
+14% +$5.29M 0.01% 1089
2020
Q4
$32M Sell
682,000
-4,600
-0.7% -$199K 0.01% 1331
2020
Q3
$25.5M Sell
686,600
-408,300
-37% -$15.5M 0.01% 1364
2020
Q2
$40M Buy
1,094,900
+430,800
+65% +$15M 0.01% 948
2020
Q1
$20.3M Sell
664,100
-180,800
-21% -$8.02M 0.01% 1225
2019
Q4
$43.1M Sell
844,900
-242,000
-22% -$11.7M 0.02% 863
2019
Q3
$51.3M Buy
1,086,900
+593,900
+120% +$28.3M 0.02% 745
2019
Q2
$24.5M Sell
493,000
-450,000
-48% -$21.2M 0.01% 1240
2019
Q1
$40.1M Sell
943,000
-600
-0.1% -$26.5K 0.02% 823
2018
Q4
$38.7M Buy
943,600
+216,300
+30% +$9.28M 0.02% 763
2018
Q3
$34M Buy
727,300
+131,400
+22% +$6M 0.02% 996
2018
Q2
$26M Sell
595,900
-199,600
-25% -$9.31M 0.01% 1106
2018
Q1
$36.5M Buy
795,500
+590,800
+289% +$28.7M 0.02% 754
2017
Q4
$10.3M Sell
204,700
-111,700
-35% -$5.88M 0.01% 1696
2017
Q3
$16.4M Sell
316,400
-604,986
-66% -$29.5M 0.01% 1215
2017
Q2
$45.1M Buy
921,386
+166,729
+22% +$7.73M 0.04% 545
2017
Q1
$35.5M Sell
754,657
-61,486
-8% -$2.93M 0.03% 618
2016
Q4
$39.2M Buy
816,143
+163,476
+25% +$7.5M 0.04% 484
2016
Q3
$25.8M Sell
652,667
-52,173
-7% -$1.96M 0.03% 723
2016
Q2
$25M Buy
704,840
+160,782
+30% +$6.27M 0.03% 638
2016
Q1
$21.3M Buy
544,058
+152,817
+39% +$5.71M 0.03% 708
2015
Q4
$16.8M Buy
391,241
+56,436
+17% +$2.48M 0.02% 937
2015
Q3
$14.1M Buy
334,805
+21,094
+7% +$985K 0.01% 1121
2015
Q2
$15.7M Sell
313,711
-5,498
-2% -$260K 0.01% 1175
2015
Q1
$14.4M Buy
319,209
+37,587
+13% +$1.69M 0.01% 1185
2014
Q4
$13.6M Sell
281,622
-13,015
-4% -$618K 0.01% 1189
2014
Q3
$14.1M Buy
294,637
+141,933
+93% +$6.89M 0.01% 1137
2014
Q2
$7.56M Sell
152,704
-50,266
-25% -$2.35M 0.01% 1488
2014
Q1
$9.55M Sell
202,970
-4,151
-2% -$191K 0.01% 1297
2013
Q4
$9.95M Sell
207,121
-76,184
-27% -$3.42M 0.01% 1208
2013
Q3
$11.9M Sell
283,305
-115,678
-29% -$4.98M 0.02% 1006
2013
Q2
$16.3M Buy
+398,983
New +$14.7M 0.03% 771

Other funds holding MET

Citadel Advisors's MET Position: Q1 2026 in Review

Citadel Advisors reduced its MetLife (MET) stake by 45% in Q1 2026, selling an estimated $68.9M and leaving 1,132,834 shares worth $80.1M. The position accounts for 0.01% of the portfolio, ranked #967.

Citadel Advisors first reported a position in MET in Q2 2013 and has held it in 48 quarters since. The position peaked at $268M in Q4 2013. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Citadel Advisors held 1,132,834 shares of MetLife worth $80.1M as of Q1 2026.
  • Citadel Advisors sold 919,866 MetLife shares in Q1 2026, an estimated $68.9M.
  • MetLife made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #967 holding.
  • Citadel Advisors first reported a position in MetLife in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's MetLife position peaked at $268M in Q4 2013.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.